Astrazeneca reported $4.46B in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Astrazeneca AZN:US USD 4.46B 359M
AstraZeneca AZN:LN USD 4.46B 359M
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Canopy Growth Corp WEED:CN CAD 318.43M 6.29M
Catalent CTLT:US USD 281M 168M
Corcept Therapeutics CORT:US USD 50.24M 14.9M
Eli Lilly And LLY:US USD 2.62B 5.5M
Endo International Ordinary Shares ENDP:US USD 1.05B 137.68M
Genmab GEN:DC DKK 10.38B 561M
GlaxoSmithKline GSK:LN GBP 3.61B 2.86B
Horizon Pharma HZNP:US USD 2.13B 237.96M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Lannett LCI:US USD 77.92M 9.94M
Novartis NOVN:VX USD 8.73B 5.1B
Pacira Pharmaceuticals PCRX:US USD 109.42M 12.64M
Perrigo Ordinary Shares PRGO:US USD 468.7M 16.6M
Phibro Animal Health PAHC:US USD 76.28M 2.03M
Prestige Brands PBH:US USD 42.44M 6.57M
Roche Holding ROG:VX 4.32B 2.54B
Supernus Pharmaceuticals SUPN:US USD 111.49M 61.94M
Teva Pharmaceutical Industries TEVA:US USD 2.22B 167M
Valeant Pharmaceuticals VRX:CN USD 486M 173M
Zoetis ZTS:US USD 2.5B 145M